Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages.

Cell banking provides a characterized, common starting source for each manufactured lot of product, and assures that an adequate supply of equivalent cells exist for use during the entire lifespan of the product

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisition by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, in June 2021, Generate Life Sciences, a life sciences company, announced that it has acquired the Cell Care Group, an international cord blood banking group that comprises cell care in Australia. Cell Care joins Generate's Cord Blood Registry in creating a global network of newborn stem cell (umbilical cord blood and tissue) banks from which to further their collective regenerative medicine research, while also providing Canadian and Australian families with greater access to reproductive and genetic services that help grow and protect healthy families from preconception into adulthood

The increasing adoption of organic growth strategies such as facility expansion by key players in the market to expand their product portfolio is expected to drive market growth over the forecast period. For instance, on April 6, 2023, Avid Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced the completion of two expansions within the company’s mammalian cell facilities. The newly expanded manufacturing capacity includes both upstream and downstream CGMP manufacturing suites and serves as a complement to Avid’s existing Myford facility, providing increased capacity to address the needs of both existing and future mammalian cell business customers

Key features of the study:

• This report provides in-depth analysis of the global GMP cell banking services market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global GMP cell banking services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global GMP cell banking services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell banking services market

Detailed Segmentation:

• Global GMP Cell Banking Services Market, By Cell Type:
  • Mammalian
  • Microbial
  • Insect
  • Yeast
  • Avian
  • Stem Cell Type
  • Others
• Global GMP Cell Banking Services Market, By End User:
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
• Global GMP Cell Banking Services Market, By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • WuXi AppTec Group*
  • Charles River Laboratories International, Inc.,
  • Eurofins Scientific
  • Merck KGaA
  • Lonza Group Ltd.
  • SGS Ltd.
  • ViruSure GmbH
  • Austrianova
  • Goodwin Biotechnology Inc.
  • Paragon Bioservices, Inc.